Why Science Applications International stock moved?
Updated Aug 6 at 2:04pm ET.
$124.28
Loading…
What's happening with the stock
SAIC rose about 4 percent today, its second straight day of gains, and is now trading at its highest point in months. We think this is mostly about a new $400 million intelligence contract that adds to an already large backlog of work.
Our view
Winning large, multi-year contracts is exactly how this business grows its predictable stream of revenue. If you already own the stock, there is nothing to do here but sit tight and let those contracts turn into cash.
The company won a $400 million contract to continue its work for a U.S. intelligence agency. This is a recompete win, which means the company successfully defended a piece of business it already held against rivals who tried to take it.
For a government contractor, winning these renewals is just as important as finding new work. It keeps the company's massive $22.9 billion backlog steady and proves that its deep technical integration with the military and intelligence groups makes it hard to replace.
The U.S. Navy awarded the company a new $70 million task order for radar engineering and technical support. The work involves modeling and simulation for the Naval Surface Warfare Center. While this is a smaller deal compared to the multi-billion dollar backlog, it fits the company's goal of doing more high-end engineering work. These technical services often earn more profit per dollar than basic IT support.
Science Applications International analyst price targets
Analysts have recently kept their ratings steady despite a series of new government contract wins. Only 8 of 18 analysts recommend buying the stock, and the average target price of $112 sits 10% below the current share price.
Average target$111.75-10%vs $124.28 today
TodayAvg price
Low $95High $137
Hold18 analysts
1Bearish
9Neutral
8Bullish
FirmRatingPrice TargetDate
Goldman Sachs
Sell
$85→$96
6/11/2026
UBS
Neutral
$113→$119
6/3/2026
Stifel Nicolaus
Buy
$120→$137
6/1/2026
BNP Paribas
Neutral
$95
5/27/2026
Goldman Sachs
Sell
$94→$82
2/12/2026
UBS
Neutral
$110→$113
12/8/2025
Jefferies
Hold
$130→$115
9/10/2025
Goldman Sachs
Sell
$104→$91
9/6/2025
Stifel Nicolaus
Buy
$130→$128
9/5/2025
Truist Financial
Hold
$110
9/4/2025
Barclays
Equal Weight
$115→$105
6/9/2025
Jefferies
Hold
$120→$130
5/15/2025
Science Applications International earnings
Management has a habit of setting a bar they can clear, beating expectations in six of the last seven quarters by a wide margin.
Earnings history
EstimateBeatMiss
Science Applications International past earnings results
Expected
Actual
Surprise
EPS
$2.28
$3.23
+41.7%
Revenue
$1.82B
$1.91B
+4.6%
Key highlights
Profitability margins jumping: The company adjusted its operating margin, which measures how much profit is made on every dollar of sales after paying costs, to 11.6% from 8.4% a year ago. This increase was driven by a $12 million gain from selling an investment and better profit across its contract portfolio.
Winning new business: The company recorded $2.1 billion in new bookings this quarter, resulting in a book to bill ratio of 1.1. This means the company is bringing in new work faster than it is completing old work, which is a key indicator of future growth.
Shrinking the share count: Management spent $175 million to buy back its own shares, which helped lower the total number of shares outstanding to 44 million from 47.8 million last year. This move makes each remaining share more valuable by giving owners a larger piece of the company's total profit.
Modest organic growth: Revenue grew just 0.5% when ignoring the impact of acquisitions, reaching $1.91 billion for the quarter. While total sales rose 2% compared to last year, most of that boost came from the $19 million added by the recently purchased SilverEdge business.
Full year outlook raised: Management raised its full year profit forecast and now expects adjusted earnings between $9.90 and $10.10 per share, up from the previous high of $9.70. The company kept its revenue goal steady at a range of $7.0 billion to $7.2 billion, suggesting it is becoming more efficient at making money on its existing sales.
Our take: A very strong start to the year, defined by a significant jump in profit margins that easily cleared previous targets. While underlying sales growth remains slow at just 0.5%, the massive raise to earnings guidance and steady new contract wins strengthen the case for the company's long term efficiency plan.
Science Applications International’s next earnings date
Q2 2027
SEP
3
Expectation
EPS
$2.31
Revenue
$1.76B
Metrics we are tracking
Metric
Expectations
Status
Total Backlog
Staying above $22.5 billion
$22.9B as of Q1 FY2027
Book-to-Bill Ratio
Maintaining a ratio above 1.0
1.1 in Q1 FY2027
EBITDA Margin
Trending toward 12.0%
11.6% in Q1 FY2027
Free Cash Flow
Exceeding $600 million annually
$118M in Q1 FY2027
More Science Applications International coverage from around the web